Neonatal Clinical Pharmacology

Karel Allegaert; Nadir Yalcin; Robert B. Flint; Sinno H. P. Simons

doi:10.3390/children11091102

Children (Sep 2024)

Neonatal Clinical Pharmacology

Karel Allegaert,
Nadir Yalcin,
Robert B. Flint,
Sinno H. P. Simons

Affiliations

Karel Allegaert: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
Nadir Yalcin: Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara 06100, Türkiye
Robert B. Flint: Department of Hospital Pharmacy, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
Sinno H. P. Simons: Department of Paediatric and Neonatal Intensive Care, Division of Neonatology, Erasmus University Medical Centre-Sophia Children’s Hospital, 3015 GD Rotterdam, The Netherlands

DOI: https://doi.org/10.3390/children11091102
Journal volume & issue: Vol. 11, no. 9
p. 1102

Abstract

Read online

Similar to other populations, care of neonates strongly relies on robust guidance on neonatal pharmacotherapy, covering an age-appropriate drug formulation, an individualized dose, and information on its efficacy and safety for a specific indication in this population, preferably weighted to alternative approaches [...]

n/a

Published in Children

ISSN: 2227-9067 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Pediatrics
Website: http://www.mdpi.com/journal/children

About the journal

Abstract

Keywords